Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126209661 | 12620966 | 1 | I | 20160724 | 20160804 | 20160804 | EXP | CZ-ACCORD-042883 | ACCORD | KOCAKOVA I, KOCAK I; AFLIBERCEPT RANKING IN LONG-TERM DISEASE CONTROL IN PATIENTS WITH METASTATIC COLORECTAL CANCER: PHARMACOTHERAPY 2016; 6(1): 1-76 | 55.00 | YR | M | Y | 0.00000 | 20160804 | MD | CZ | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126209661 | 12620966 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | U | 202593 | Q3W | |||||||||
| 126209661 | 12620966 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | 200750096 | Q3W | |||||||||||
| 126209661 | 12620966 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 40743 | ||||||||||||
| 126209661 | 12620966 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | 79068 | ||||||||||||
| 126209661 | 12620966 | 5 | SS | AVASTIN | BEVACIZUMAB | 1 | U | 0 | |||||||||||
| 126209661 | 12620966 | 6 | SS | ZALTRAP | ZIV-AFLIBERCEPT | 1 | U | 0 | |||||||||||
| 126209661 | 12620966 | 7 | C | LEUCOVORIN. | LEUCOVORIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126209661 | 12620966 | 1 | Rectosigmoid cancer |
| 126209661 | 12620966 | 2 | Rectosigmoid cancer |
| 126209661 | 12620966 | 3 | Rectosigmoid cancer |
| 126209661 | 12620966 | 4 | Rectosigmoid cancer |
| 126209661 | 12620966 | 5 | Rectosigmoid cancer |
| 126209661 | 12620966 | 6 | Rectosigmoid cancer |
| 126209661 | 12620966 | 7 | Rectosigmoid cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126209661 | 12620966 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126209661 | 12620966 | Gastrointestinal toxicity | |
| 126209661 | 12620966 | Hypertension | |
| 126209661 | 12620966 | Neurotoxicity | |
| 126209661 | 12620966 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |